Pharmaceuticals

Potential solutions to drug shortages and the lack of competition in generic medicines

10 Aug 2018

Novartis to pay up to $1 bn for experimental skin drug

20 Jul 2018

Aurobindo acquires Apotex's business in 5 European countries for €74 mn

16 Jul 2018

China may ease entry norms for Indian pharma if US trade war hurts

14 Jul 2018

India asks Beijing to lower barriers for meat, pharma and IT exports

13 Jul 2018

New compounds to treat RSV, Zika virus identified

12 Jul 2018

Stop antibiotics before resistance 'tipping point'

11 Jul 2018

Novartis plans to spin off eye care division Alcon; buy back, $5 bn shares

29 Jun 2018

LyondellBasell in talks to acquire Brazilian plastics maker Braskem

16 Jun 2018

A new kind of vaccine based on spider silk developed

15 Jun 2018

Sun Pharma gets US FDA clearance for its Halol plant

13 Jun 2018

Biocon - Mylan’s biosimilar cancer drug `Fulphilia’ gets US FDA approval

06 Jun 2018

Tax hurts investment in medical device research and development

06 Jun 2018

Clinical trials in a dish: the coming revolution in drug development

06 Jun 2018

Most popular vitamin, mineral supplements provide no health benefit, study finds

31 May 2018

A new study suggests most common vitamin and mineral supplements have no consistent benefit for the prevention of cardiovascular disease, heart attack, stroke or premature death

Drug companies selling more 'lifestyle,' less 'symptom'

16 May 2018

Eli Lilly to buy privately-held AurKa Pharma in a deal potentially worth $575 mn

14 May 2018

Canadian medical marijuana provider Aurora Cannabis to buy MedReleaf for $2.5 bn

14 May 2018

Aurobindo and others in the race to buy Novartis portfolio of US assets

12 May 2018

If Aurobindo Pharma is successful in clinching the deal, it would be the largest acquisition of an overseas business by any Indian drug producer, after Lupin's 2015 acquisitions of Gavis Pharmaceuticals and Novel Laboratories for $880 million, in a cash-free and debt deal

Eli Lilly to buy Armo BioSciences for $1.6 bn

11 May 2018

US pharmaceutical company Eli Lilly and Co yesterday struck a deal to buy Armo BioSciences Inc for about $1.6 billion in order to strengthen its immuno-oncology portfolio

Delhi High court allows sale of Ranbaxy ex promoter's unencumbered assets

09 May 2018

How pharma companies can help safeguard intellectual property when expanding into risky countries

09 May 2018

Takeda Pharmaceutical to buy larger Irish rival Shire for $62 bn

08 May 2018

In one of the biggest deals in the pharmaceutical industry's history and the biggest international takeover by a Japanese company, Takeda Pharmaceutical today struck a deal to buy its larger Irish rival Shire Plc for $62 billion

Aurobindo in race to acquire generic dermatology business from Novartis

07 May 2018

India to benefit as China lifts import duties on 28 drugs: Chinese envoy

04 May 2018